Hans Prydz

8.6k total citations · 1 hit paper
205 papers, 7.1k citations indexed

About

Hans Prydz is a scholar working on Molecular Biology, Hematology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hans Prydz has authored 205 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 78 papers in Hematology and 41 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hans Prydz's work include Blood Coagulation and Thrombosis Mechanisms (49 papers), Hemophilia Treatment and Research (41 papers) and Blood properties and coagulation (39 papers). Hans Prydz is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (49 papers), Hemophilia Treatment and Research (41 papers) and Blood properties and coagulation (39 papers). Hans Prydz collaborates with scholars based in Norway, United States and United Kingdom. Hans Prydz's co-authors include Eric Camerer, Torstein Lyberg, Frank Larsen, P Brandtzæg, Rodrigo López, Glenn Gundersen, Mohammed Amarzguioui, Anne-Brit Kolstø, Jens‐Gustav Iversen and Elisabet Gjernes and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Hans Prydz

203 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CpG islands as gene markers in the human genome

1992 690 citations Frank Larsen, Glenn Gundersen et al. Genomics profile →

Peers

Countries citing papers authored by Hans Prydz

Since Specialization

Citations

This map shows the geographic impact of Hans Prydz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Prydz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Prydz more than expected).

Fields of papers citing papers by Hans Prydz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Prydz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Prydz. The network helps show where Hans Prydz may publish in the future.

Co-authorship network of co-authors of Hans Prydz

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Prydz. A scholar is included among the top collaborators of Hans Prydz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Prydz. Hans Prydz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Facile Lentiviral Vector System for Expression of Doxycycline-Inducible shRNAs: Knockdown of the Pre-miRNA Processing Enzyme Drosha 2007 ·Molecular Therapy ·Lars Aagaard, Mohammed Amarzguioui, Guihua Sun, LETÍCIA VITÓRIA DA SILVA SANTOS, Ali A. Ehsani, Hans Prydz, John J. Rossi	44
2	Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease 2004 ·Thrombosis Research ·Anja Schou Lindman, Jan I. Pedersen, Harald Arnesen, Elsa M. Hjerkinn, Marit B. Veierød, Hans Prydz, Ingebjørg Seljeflot	12
3	The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells 2004 ·Thrombosis and Haemostasis ·Merete Thune Wiiger, Hans Prydz	24
4	Knockdown of C‐terminal Src kinase by siRNA‐mediated RNA interference augments T cell receptor signaling in mature T cells 2004 ·European Journal of Immunology ·Torkel Vang, Hilde Abrahamsen, (unknown), Jorrit M. Enserink, Hans Prydz, Tomas Mustelin, Mohammed Amarzguioui, Kjetil Taskén	37
5	A novel gene mutation in the 60s loop of human coagulation factor VII – inhibition of interdomain crosstalk 2003 ·Thrombosis and Haemostasis ·(unknown), Merete Thune Wiiger, (unknown), Helge Stormorken, Hans Prydz	2
6	Transport Signals and Transcription-dependent Nuclear Localization of the Putative DEAD-box Helicase MDDX28 2003 ·Journal of Biological Chemistry ·Rut Valgardsdottir, Hans Prydz	11
7	ESF Workshop on ‘Impact of Nucleic Acid Chemistry on Gene Function Analysis: Antisense, Aptamers, Ribozymes and RNAi’ 2002 ·Comparative and Functional Genomics ·Kathrin Heermeier, Hans Prydz, (unknown), Joachim W. Engels	2
8	Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors 2002 ·Oncogene ·Keltouma Driouch, Hans Prydz, (unknown), (unknown), Rosette Lidereau, Eirik Frengen	91
9	High-Resolution Integrated Map Encompassing the Breast Cancer Loss of Heterozygosity Region on Human Chromosome 16q22.1 2000 ·Genomics ·Eirik Frengen, Philippe Rocca‐Serra, Sergey Shaposhnikov, Laurence Taine, Jim Thorsen, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Michel Longy, Hans Prydz, Françoise Dorion-Bonnet	12
10	Effects of hTNFα expression in T cells on haematopoiesis in transgenic mice 1999 ·European Journal Of Haematology ·Heidi Glosli, O. Petter Veiby, (unknown), (unknown), Lesley Probert, George Kollias, Elisabet Gjernes, Hans Prydz	12
11	Interaction of the CNC-bZIP factor TCF11/LCR-F1/Nrf1 with MafG: Binding-site selection and regulation of transcription 1998 ·Nucleic Acids Research ·Ø. Johnsen, Paula Murphy, Hans Prydz, (unknown)	104
12	Cell biology of tissue factor, the principal initiator of blood coagulation 1996 ·Thrombosis Research ·Eric Camerer, Anne-Brit Kolstø, Hans Prydz	335
13	Tissue-specific Expression of the Human Gene for Lecithin: Cholesterol Acyltransferase in Transgenic Mice Alters Blood Lipids, Lipoproteins and Lipases towards a Less Atherogenic Profile 1995 ·European Journal of Biochemistry ·(unknown), Bart Staels, Nicolas Duverger, Anne Tailleux, (unknown), Catherine Fiévet, Gérald Luc, Jean‐Charles Fruchart, Gunilla Olivecrona, (unknown), Johan Auwerx, Hans Prydz	49
14	Regulation of lecithin: Cholesterol acyltransferase by TGF-β and interleukin-6 1995 ·Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism ·(unknown), Elisabet Gjernes, Hans Prydz	19
15	Physical linkage of the gene cluster containing the LCAT gene to the DNA marker D16S124 at human chromosome region 16q22.1 1995 ·Cytogenetic and Genome Research ·Eirik Frengen, Gaute Brede, Frank Larsen, Grethe Skretting, Hans Prydz	5
16	1 kb of the lactase‐phlorizin hydrolase promoter directs post‐weaning decline and small intestinal‐specific expression in transgenic mice 1994 ·FEBS Letters ·Jesper T. Troelsen, (unknown), Jørgen Olsen, Nikolaj Spodsberg, Gert H. Hansen, Hans Prydz, Ove Norén, Hans Sjöström	47
17	CpG islands as gene markers in the human genome breakdown → 1992 ·Genomics ·Frank Larsen, Glenn Gundersen, Rodrigo López, Hans Prydz	690
18	Association analysis of lipid levels and apolipoprotein restriction fragment length polymorphisms 1990 ·Human Genetics ·Ola Myklebost, Sissel Rogne, Ingvar Hjermann, (unknown), Hans Prydz	12
19	Activation of Monocytes—More than One Process 1988 ·Scandinavian Journal of Immunology ·Erik Carlsen, Hans Prydz	22
20	Studies on Proconvertin (Factor VII) V. Biosynthesis in Suspension Cultures of Rat Liver Cells 1964 ·Scandinavian Journal of Clinical and Laboratory Investigation ·Hans Prydz	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact